Atopic Dermatitis, or more commonly known as Eczema, is an inflammatory skin disease characterized by a small to moderately sized rash that can appear anywhere on the skin. It can be lasting and aggravating for those who suffer and has no outright cure. There are several topical treatments, but nothing that can guarantee a reduction or cure for AD.
Because of this, QCR is testing an investigational medication on eligible subjects for 8 weeks in order to determine the safety and efficacy of the medicine. We are looking for primarily pediatric participation with limited adult participation.
To qualify for this study, you must be:
- 2 years of age or older
- Have a clinical diagnosis of AD
- AD must be present for at least 6 months for ages 6 and older or 3 months for those between 2 and 5
- Other criteria may apply during screening
Compensation for time and travel will be available to enrolled subjects
To learn more about this trial and to find out if you qualify, please call 402-934-0044 or complete the form on our contact page.